Health Care·Pharmaceuticals·$2.8B
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.07 | N/A | -66.35% |
| Revenue | N/A | N/A | N/A |
management commentary, guidance changes, and full analysis available with Pro.
| EPS | $0.07 | N/A | -66.35% |
| Revenue | N/A | N/A | N/A |
Tone: Defensive
Management acknowledged the difficulties faced in the quarter and highlighted the need for strategic adjustments. They did not provide specific guidance for future performance.
Management expressed concerns about current market conditions affecting performance.
They noted challenges in achieving growth targets for the upcoming period.
This earnings report indicates that Prestige Consumer HE is facing significant challenges, particularly reflected in their EPS miss. The stock reaction, a decline of 19.31%, suggests investor concern over the company's ability to navigate current market conditions. Without guidance, uncertainty remains about future performance and recovery strategies.
AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.
No charge today · Auto-bills $8/mo after 7 days · Cancel anytime
NRG ENERGY INC
May 10, 2010